Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of DAB2 mRNA | increases expression | 16788091
|
D000450 |
Aldosterone |
AGT protein affects the reaction [DAB2 protein results in increased secretion of Aldosterone] | affects reaction|increases secretion | 17303656
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DAB2 mRNA | affects expression | 16483693
|
D001149 |
Arsenates |
Arsenates results in decreased expression of DAB2 mRNA | decreases expression | 12773770
|
D001205 |
Ascorbic Acid |
Ascorbic Acid results in decreased expression of DAB2 mRNA | decreases expression | 15305145
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of DAB2 mRNA | decreases expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of DAB2 mRNA | increases expression | 20713471
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DAB2 mRNA | decreases expression | 20018196 19150397
|
C095105 |
bexarotene |
bexarotene results in decreased expression of DAB2 mRNA | decreases expression | 16648578
|
D019256 |
Cadmium Chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of DAB2 mRNA | affects cotreatment|decreases expression | 12634122
|
C023600 |
chromium oxide |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of DAB2 mRNA | affects cotreatment|decreases expression | 12634122
|
C017133 |
chromous chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of DAB2 mRNA | affects cotreatment|decreases expression | 12634122
|
D002945 |
Cisplatin |
DAB2 protein results in decreased susceptibility to Cisplatin | decreases response to substance | 16734730
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of DAB2 mRNA | decreases expression | 18042831
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of DAB2 mRNA | increases expression | 19638242
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DAB2 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of DAB2 mRNA | increases expression | 19619570
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of DAB2 mRNA | affects expression | 17351261
|
D005047 |
Etoposide |
DAB2 protein affects the susceptibility to Etoposide | affects response to substance | 16217747
|
C056516 |
exemestane |
exemestane results in increased expression of DAB2 mRNA | increases expression | 17254854
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in increased expression of DAB2 mRNA | increases expression | 16849584
|
C005134 |
juglone |
juglone affects the phosphorylation of DAB2 protein | affects phosphorylation | 12881709
|
C008261 |
lead acetate |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of DAB2 mRNA | affects cotreatment|decreases expression | 12634122
|
D019216 |
Metals, Heavy |
Metals, Heavy results in decreased expression of DAB2 mRNA | decreases expression | 12773770
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of DAB2 mRNA | increases expression | 20713471
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of DAB2 mRNA | increases expression | 12634122 12773770
|
D019319 |
Okadaic Acid |
Okadaic Acid affects the phosphorylation of DAB2 protein | affects phosphorylation | 12881709
|
C041786 |
palm oil |
palm oil results in decreased expression of DAB2 mRNA | decreases expression | 18042831
|
D010795 |
Phthalic Acids |
Phthalic Acids results in increased expression of DAB2 mRNA | increases expression | 15728792
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DAB2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C488333 |
Ro 65-7199 |
Ro 65-7199 results in decreased expression of DAB2 mRNA | decreases expression | 14610520
|
C488334 |
Ro 66-0074 |
Ro 66-0074 affects the expression of DAB2 mRNA | affects expression | 14610520
|
C104586 |
roscovitine |
roscovitine results in decreased phosphorylation of DAB2 protein | decreases phosphorylation | 12881709
|
C104586 |
roscovitine |
roscovitine results in decreased phosphorylation of DAB2 protein | decreases phosphorylation | 12881709
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of DAB2 mRNA | affects cotreatment|decreases expression | 12634122
|
D017673 |
Sodium Chloride, Dietary |
Sodium Chloride, Dietary affects the expression of DAB2 mRNA alternative form | affects expression | 17303656
|
D017673 |
Sodium Chloride, Dietary |
Sodium Chloride, Dietary affects the expression of DAB2 protein alternative form | affects expression | 17303656
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of DAB2 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DAB2 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of DAB2 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of DAB2 mRNA | increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of DAB2 mRNA | increases expression | 18691609 19933214
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of DAB2 mRNA | increases expression | 18230668
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of DAB2 mRNA | increases expression | 17138961
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of DAB2 mRNA | increases expression | 16788091
|
C025643 |
vinclozolin |
vinclozolin affects the expression of DAB2 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.47 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.18 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.55 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.62 | 15814532 17670903 12690470 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.77 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.27 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
9.27 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.27 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.27 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
9.92 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
9.92 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
9.92 | 6695378 10545420 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
15.07 | 16434500 17620307 19061943 18056438 19052882 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
15.07 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.07 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.31 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.51 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.32 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Metals, Heavy |
4.22 | 17430250 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.62 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.34 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.70 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
8.67 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
8.67 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.41 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.41 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.17 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.22 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.23 | 11922910 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Phthalic Acids |
4.10 | 20106747 |
MESH:D001327 |
Autoimmune Diseases |
|
Metals, Heavy |
5.81 | 16045731 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.04 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
13.30 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.30 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.30 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.40 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.52 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
10.93 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
10.93 | 14601052 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
9.10 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
9.10 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
9.10 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
9.10 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
9.10 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
9.10 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
9.10 | 17289903 18497071 12948864 17261762 14630087 17018787 16675129 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
9.10 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
exemestane |
9.10 | 17892469 16002280 17952589 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
9.10 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
9.10 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
9.10 | 16443354 16166294 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.21 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.08 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
7.34 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.34 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.77 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
8.12 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
8.12 | 18393292 16540662 17055752 16502159 3581430 16830150 3084413 19208518 19171122 16569478 19919837 16935385 16288022 18978308 19052882 20214788 17138121 20727157 19539802 16698587 17761372 16328049 19519916 20512989 17978847 19822196 19394651 19107877 18788625 19383236 10672840 18971187 19701751 20524982 16878318 17162532 16807293 20101231 20514400 20007298 20084675 18056438 18506893 16681979 19335982 18691550 18785209 20935162 17173139 20432363 18210153 18494052 17428255 19418558 16779866 11831363 18665156 21159647 10737359 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.12 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.12 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.12 | 1917145 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
5.40 | 16247446 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
5.40 | 12023789 16685392 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
9.79 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
9.79 | 17066447 6189445 18337622 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
9.79 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
9.79 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.15 | 18850075 16120746 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Aldosterone |
4.46 | 11230374 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.87 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
22.95 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
22.95 | 7505956 21159647 17174075 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
22.95 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
22.95 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
22.95 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
22.95 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.21 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.26 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.81 | 15861022 16105132 17110522 17681005 17333356 11677210 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
6.81 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.77 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.20 | 8697196 12621046 15668235 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.20 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.33 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.32 | 15273666 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
5.09 | 17323712 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.74 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
3.66 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.66 | 9224671 17551590 16925845 9664655 9142499 10589399 9125849 14991402 8800419 9211117 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
3.98 | 14966744 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.24 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
6.56 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.56 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.56 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.09 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.33 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.33 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
7.24 | 12649298 15033597 19839026 12231392 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.24 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.18 | 18367378 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
5.09 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.43 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.43 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.65 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.65 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
2.83 | 12538720 |
MESH:D016643 |
Encephalopathy, Bovine Spongiform |
|
Metals, Heavy |
6.93 | 16481041 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.58 | 18566989 19148513 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.58 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.69 | 10568697 9294722 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.73 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.63 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.63 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
6.63 | 17638652 15173087 16785472 15464296 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.90 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.90 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
15.97 | 19551842 17967931 18296743 19004024 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
15.97 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
15.97 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
15.97 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.08 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
5.02 | 19769572 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.56 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
12.62 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.62 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
12.62 | 17994277 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.55 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.91 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.30 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Okadaic Acid |
6.88 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.88 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.21 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
7.05 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.05 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.98 | 19898482 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.77 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.11 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
14.30 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
14.30 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
14.30 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
14.30 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.30 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.00 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.03 | 19772884 18467677 19176532 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.03 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
3.34 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.64 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.18 | 10809021 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.36 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
10.57 | 16170182 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
10.57 | 15147373 18180244 16135485 17606976 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
10.57 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.37 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.66 | 18606429 15340226 16959395 8697196 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
2.92 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.26 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.20 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.85 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.27 | 21332399 |
MESH:D006973 |
Hypertension |
|
Sodium Chloride, Dietary |
5.35 | 18524855 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.35 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.44 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.11 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
9.72 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
9.72 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
9.72 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
7.09 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
7.09 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.09 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
10.83 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
10.83 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
10.83 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.40 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.80 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.80 | 17551590 15992940 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.75 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
12.67 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
12.67 | 12649298 15190930 19839026 18289764 12231392 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
12.67 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
12.67 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.68 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.41 | 11231351 |
MESH:D007938 |
Leukemia |
|
roscovitine |
6.36 | 16275999 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.36 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.36 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.01 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.90 | 17301526 17712046 16140955 9834237 17107899 16891316 16766008 19075265 19035177 17649720 17339181 17361223 17217047 17506722 15748426 16823087 19642359 12679006 16331271 16788101 19029980 17294898 19225113 17368321 16935935 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.35 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.04 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
5.92 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
5.92 | 20032147 19638242 18665156 18407596 18522880 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.17 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Metals, Heavy |
6.17 | 15383259 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.17 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.17 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.17 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.01 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
12.57 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
12.57 | 20501860 19850985 21071580 20434301 16942905 21167192 19642983 19294768 19833225 18977376 15885732 20101389 19090486 19996281 2862719 18648771 19427195 20583210 9163691 19255062 2422723 19812893 19256749 20137499 19073162 10737359 19551842 21278145 18978307 20452335 20118626 19254457 18754104 15175105 18644402 19426721 21047994 12112319 20492335 20405173 19690152 12771043 19638242 19499222 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
12.57 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
12.57 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
12.57 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
12.20 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
12.20 | 18282651 17942915 17854601 19009564 16842330 18775883 18308698 18544905 21159647 3124819 17174075 19539802 19126423 16267830 19519916 18079962 18253720 19004024 18164116 9362446 18093689 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
12.20 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.20 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
6.87 | 16863852 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.87 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
12.01 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
12.01 | 17053015 20064080 6695378 20869020 18520028 18569708 20135361 20464547 18816296 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
12.01 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
12.01 | 6189445 11798837 17225452 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
12.01 | 6695378 20970405 20512841 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
12.01 | 17909032 16337739 10545420 21163286 11893704 16271038 20970405 9230183 20512841 7750092 6695378 15390079 1399818 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
12.01 | 17077188 16712894 19931552 17306315 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
12.01 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
3.65 | 12854902 12556972 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.77 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
5.44 | 19196722 19196723 15591091 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.44 | 11408345 11807958 17203775 16891317 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.09 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.63 | 17453147 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
4.72 | 16248763 18176117 15577323 16809738 18505091 12393984 16432458 17023156 12374674 17761969 18332650 11135225 12883367 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.72 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.72 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.39 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.05 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.09 | 17638057 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.51 | 17671175 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.90 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.14 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.86 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
1.98 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.72 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.28 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.28 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.41 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
13.63 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
13.63 | 16773208 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
13.63 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
13.63 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
13.63 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.30 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.40 | 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.35 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.11 | 15464296 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.24 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.24 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
14.24 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.48 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.48 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.25 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.03 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.32 | 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.73 | 20387270 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
6.86 | 17217161 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
6.86 | 19632207 18674790 21332399 20132043 17217161 18457598 11836018 16723640 20518802 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
6.86 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
10.22 | 19769630 17225452 15464296 6897625 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.22 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.22 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
10.22 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.61 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
11.17 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
11.17 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
11.17 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
11.17 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.34 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.86 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.95 | 15464296 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
4.95 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.20 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.23 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.22 | 11222880 11896295 11399792 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
8.22 | 18042343 18220299 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.55 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.54 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.93 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.93 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
1.93 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
roscovitine |
1.93 | 16140939 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.93 | 16039940 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.55 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.26 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.93 | 15861022 16919318 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.41 | 16723453 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
4.94 | 14606601 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
4.04 | 15464296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.20 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.47 | 18990726 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
3.20 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.75 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
15.50 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
15.50 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
roscovitine |
15.50 | 16230394 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
3.11 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
15.95 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Okadaic Acid |
15.95 | 12628509 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
15.95 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
15.95 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
15.95 | 16467112 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.95 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.55 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.50 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.37 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
4.37 | 18396642 17522103 15958060 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.37 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.37 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
3.56 | 18726076 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
3.99 | 16517955 16403987 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.28 | 17225452 15464296 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.27 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.83 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.51 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
6.22 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
6.22 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.30 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.46 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.99 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
7.45 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
7.45 | 17225452 12973940 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.45 | 16452187 17306315 11723127 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
14.00 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.00 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
14.00 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.94 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.22 | 16752155 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.24 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.04 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.21 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.20 | 15869587 14671159 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.69 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.33 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.86 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.42 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.65 | 16287080 |